MARY PRUITT: Open Payments
NPI 1275841199 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 73 payments from 20 companies in 2025. Trend: 2023 $1,109 · 2024 $1,404 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $265 |
| AstraZeneca Pharmaceuticals LP | 4 | $237 |
| PFIZER INC. | 12 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $150 |
| Astellas Pharma US Inc | 7 | $142 |
| Novo Nordisk Inc | 6 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Dexcom, Inc. | 3 | $57 |
| Boston Scientific Corporation | 1 | $57 |
| Amgen Inc. | 4 | $55 |
Products named: Kerendia, Veozah, BREZTRI, NURTEC ODT, UBRELVY, QULIPTA, AIRSUPRA, CAPLYTA.
Industry payments across VA — which companies pay providers there.
